Table 2 Participants’ characteristics and differences among these variables between the two groups at baseline (N = 125)
Variable | Total | Control group (n = 61) | Intervention group (n = 64) | t | P value |
|---|---|---|---|---|---|
Mean (SD) | Mean (SD) | Mean (SD) | |||
Age, years | 37.1 (14.1) | 38.4 (15.8) | 35.9 (12.3) | 1.015 | 0.312 |
SLEDAI-2K | 10.3 (4.4) | 9.7 (3.8) | 10.9 (4.9) | −1.584 | 0.116 |
Variable | n (%) | n (%) | n (%) | χ 2 | P value |
Gender | |||||
 Male | 14 (11.2) | 7 (11.5) | 7 (10.9) | 0.009 | 0.924 |
 Female | 111 (88.8) | 54 (88.5) | 57 (89.1) | ||
Education level | |||||
 High school or less | 60 (48.0) | 30 (49.2) | 30 (46.9) | 0.066 | 0.797 |
 Above high school | 65 (52.0) | 31 (50.8) | 34 (53.1) | ||
Marital status | |||||
 Married | 92 (73.6) | 47 (77.0) | 45 (70.3) | 0.729 | 0.393 |
 Single | 33 (26.4) | 14 (23.0) | 19 (29.7) | ||
Work status | |||||
 Employed | 27 (21.6) | 12 (19.7) | 15 (23.4) | 0.261 | 0.609 |
 Unemployed | 98 (78.4) | 49 (80.3) | 49 (76.6) | ||
Medical insurance | |||||
 Yes | 82 (65.6) | 39 (63.9) | 43 (67.2) | 0.146 | 0.702 |
 No | 43 (34.4) | 22 (36.1) | 21 (32.8) | ||
Diagnosis duration | |||||
 ≤3 years | 63 (50.4) | 30 (49.2) | 33 (51.6) | 0.071 | 0.790 |
 >3 years | 62 (49.6) | 31 (50.8) | 31 (48.4) | ||
Hospitalizations (past 1 year) | |||||
 Yes | 81 (64.8) | 40 (65.6) | 41 (64.1) | 0.031 | 0.860 |
 No | 44 (35.2) | 21 (34.4) | 23 (35.9) | ||
Comorbidity | |||||
 Yes | 109 (87.2) | 51 (83.6) | 58 (90.6) | 1.378 | 0.240 |
 No | 16 (12.8) | 10 (16.4) | 6 (9.4) | ||
Type of SLE medicine | |||||
 GC | 21 (16.8) | 11 (18.0) | 10 (15.6) | 0.844 | 0.839 |
 GC plus HCQ | 65 (52.0) | 32 (52.5) | 33 (51.6) | ||
 GC plus ISD | 20 (16.0) | 8 (13.1) | 12 (18.8) | ||
 GC plus HCQ plus ISD | 19 (15.2) | 10 (16.4) | 9 (14.1) | ||